CriticalMacrolide antibiotic×Antigout agents
Updated · Methodology
Mechanism
Colchicine is cleared via hepatic CYP3A4 and the P-glycoprotein transporter. Clarithromycin inhibits both. Colchicine plasma levels rise several-fold. The narrow therapeutic window makes any increase clinically dangerous. FDA Colcrys carries a boxed warning for fatal toxicity.
Symptoms
Profuse diarrhoea, vomiting, abdominal pain – first signs of toxicity. Pancytopenia (drop in leukocytes, erythrocytes, platelets), muscle weakness, peripheral neuropathy, hepatic and renal injury follow. Fatal cases have been reported.
Management
For patients with renal impairment (creatinine clearance below 60 mL/min) or hepatic impairment, the combination is not prescribed. With preserved renal and hepatic function, use colchicine 0.3 mg every other day, no more than 5 days. Alternative antibiotic: azithromycin (minimal interaction).
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.
Summary of a multi-drug list →
Medicine list: everything you take in one place →
Sources
- FDA: Colcrys (colchicine) prescribing information (2022)– FDA, DailyMed setid d6adc880-5499-4691-93f3-27c87902d5fc (Proficient Rx, repackaged Colcrys), revised 10/2022, sections 2.4 (Table 1), 4, 5.3, 7 and 12.3
- FDA: Colchicine tablet (Par Health USA, LLC) – Prescribing Information (2012)– ; DailyMed setid 72984aa2-6df9-4460-9926-399ffed30e36
- AEMPS: Ficha técnica: Claritromicina (nº registro 75638), sección 4.3 (2025)– AEMPS, CIMA, nº registro 75638, revisión 03/2025, sección 4.3